Patient will present as → a 32-year-old male who noticed a mass on his right testicle while showering. He reports this has never happened before and denies any pain or discomfort. On physical examination, there is a firm and fixed mass on the left testicle. Bilateral scrotal ultrasound is performed and significant findings are seen here.
Presents as a firm, painless, nontender testicular mass
- Most common solid tumor in young men ages 15-40 (average age 32 years old)
- 5 year survival is 90% in most cases
- Seminoma is the most common type (60%)
- Risk factors include history of cryptorchidism
Diagnostic studies include
- βHCG (+) and α-fetoprotein (+) in non seminoma germ cell tumors
- Scrotal ultrasound
- Radiologic studies to look for mets (common mets to belly, brain and lung)
Orchiectomy with or without chemotherapy and radiation depending on cell type.
- Seminomatous tumors are radiosensitive and can be treated with radiation therapy
- Nonseminomatous tumors are radioresistant
- **Alpha fetoprotein (AFP) can be used to identify early relapse in testicular cancer?
Surveillance is an option in stage I disease of a nonseminoma testicular tumor.
Patients with stage IIC and stage III are treated with chemotherapy.
Orchiectomy and radiation
Orchiectomy and chemotherapy
Chemotherapy is used for later stage tumors (II/III) and followed by surgery in stage III tumors.
Low socioeconomic status
High socioeconomic status, not low, is a risk factor.
History of cryptorchidism
Multiple episodes of epididymitis
Multiple episodes of epididymitis are unrelated to the development of testicular cancer.
Being of African-American ethnicity
The incidence of testicular cancer is much lower in African-American men than in Caucasian men.
serum alpha fetoprotein levels
Although tumor markers are useful to follow patients with testicular cancer, they are not used as the initial screen.
serum human chorionic gonadotropin hormone
See A for explanation.
CT scan of the pelvis
CT scanning of the pelvis is most commonly used in the evaluation for metastatic disease and not used in the initial screen for testicular cancer.
ultrasound of the testicles
Carcinoembryonic antigen (CEA)
Carcinoembryonic antigen can be elevated in multiple conditions including colon cancer, gastritis, peptic ulcer disease, diverticulitis, liver disease, chronic obstructive pulmonary disease, and diabetes.
Prostate specific antigen (PSA)
Prostate specific antigen is a sensitive marker for prostate cancer.
CA 125 glycoprotein
CA 125 glycoprotein is a marker in epithelial ovarian cancer and can be used for post-treatment surveillance.
Alpha fetoprotein (AFP)